Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study

In the Medical Research Council (MRC) Myeloma IX trial (ISRCTN684564111) patients were randomised to sodium clodronate or zoledronic acid and induction treatment: cyclophosphamide, vincristine, doxorubicin and dexamethasone (CVAD) or cyclophosphamide, thalidomide and dexamethasone (CTD) followed by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Royle, Kara‐Louise, Gregory, Walter M., Cairns, David A., Bell, Sue E., Cook, Gordon, Owen, Roger G., Drayson, Mark T., Davies, Faith E., Jackson, Graham H., Morgan, Gareth J., Child, J. Anthony
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Haematological Malignancy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175065/
https://ncbi.nlm.nih.gov/pubmed/29984830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15459
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados